Replies to post #13950 on Momenta Pharmaceuticals, Inc. (MNTA)

[indigokid]

After today's CC I guess we know why MNTA didn't pay for recent change to a 50/50 profit split on the 2003 Enox deal.

MNTA's high single digit royalty (I think I recall 8%?...) is now higher than the profit margin on the reduced sales volume of generic Enox. Funny how we thought receiving a percentage of sales was a bad thing....